Immuron Limited (IMRN)
 NASDAQ: IMRN · Real-Time Price · USD
 1.860
 -0.160 (-7.92%)
  Oct 31, 2025, 10:18 AM EDT - Market open
Immuron Employees
Immuron had 7 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees 
 7
Change (1Y) 
 n/a
Growth (1Y) 
 n/a
Revenue / Employee 
 $682,489
Profits / Employee 
 -$488,521
Market Cap 
14.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | - | 
| Jun 30, 2024 | 7 | 1 | 16.67% | 
| Jun 30, 2023 | 6 | 1 | 20.00% | 
| Jun 30, 2022 | 5 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
IMRN News
- 13 days ago - Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target - Newsfile Corp
- 18 days ago - Immuron Q1 FY26 YoY growth - GlobeNewsWire
- 23 days ago - Immuron Submits IMM-529 IND to FDA - GlobeNewsWire
- 4 weeks ago - Immuron Letter to Shareholders – Projects Update - GlobeNewsWire
- 2 months ago - Immuron partners with InvestorHub - GlobeNewsWire
- 3 months ago - Immuron - FY25 global sales exceed projection, up 49% on prior year - GlobeNewsWire
- 5 months ago - Immuron Letter to Shareholders: Projects Update - GlobeNewsWire
- 7 months ago - Immuron Travelan® highest sales in history - GlobeNewsWire